Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders have made significant purchases in NextDecade Corporation, Adverum Biotechnologies, and Texas Capital Bancshares, indicating confidence in these companies' prospects. Notable trades include Hanwha Ocean Co., Ltd's $87.7M investment in NextDecade, Braden Michael Leonard's $613,470 investment in Adverum Biotechnologies, and Robert W Stallings' $409,300 investment in Texas Capital Bancshares.
August 01, 2024 | 12:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Braden Michael Leonard acquired 85,800 shares of Adverum Biotechnologies at $7.15 per share, totaling $613,470. This insider purchase follows the FDA's RMAT designation for Ixo-vec, indicating potential growth.
The insider purchase, combined with the recent FDA RMAT designation for Ixo-vec, suggests a positive outlook for Adverum Biotechnologies, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Hanwha Ocean Co., Ltd acquired 11,690,909 shares of NextDecade Corporation at $7.50 per share, totaling $87.7M. This significant insider purchase indicates strong confidence in the company's future prospects.
The large insider purchase by a 10% owner suggests strong confidence in NextDecade's future, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Robert W Stallings bought 20,000 shares of Texas Capital Bancshares at $20.47 per share, totaling $409,300. Despite recent poor financial results, this insider purchase indicates confidence in the company's recovery.
The insider purchase suggests confidence in Texas Capital Bancshares' ability to recover from recent poor financial results, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100